Epigenetics Market 2025 By Product, Distribution Channel, Technology, Key Manufacturers | The Insight Partners

Epigenetics Market to 2025 - Global Analysis and Forecasts by Product (Reagents, Kits, Enzymes, Instruments & Consumables and Bioinformatics Tools), Technology (Histone Modification, DNA Methylation and Others), Application (Oncology, Cardiovascular Diseases and Others) End Users (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization) and Geography

Publication Month: Jan 2019 | Report Code: TIPHE100000971 | No. of Pages: 150 | Category: Biotechnology | Status: Published

The Global Epigenetics Market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017 and estimated to grow with a CAGR of 13.6% from 2018-2025.

Epigenetics market is segmented by technology, product, application and end user. Global epigenetics market, based on product the segment is segmented as reagents, kits, enzymes, instruments and consumables and bioinformatics tools. Global epigenetics market, based on the technology was segmented into histone modification, DNA methylation and other technologies. The epigenetics market, based on application was segmented into metabolic diseases, oncology, cardiovascular diseases and other applications. The epigenetics market, based on end user was segmented into contract research organizations, pharmaceutical & biotechnology companies.


The study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence is known as epigenetics. A single or multiple change in phenotype without a changing the genotype which results affects the cells that can read the genes. The report would be of an interest to various stakeholders operating in the epigenetics market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.

The objective of the study is to describe, define, and forecast the epigenetics market by technology, product, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The report analyzes factors affecting epigenetics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key epigenetics manufacturing companies along with their SWOT analysis and market strategies.

The prominent players operating in the market of epigenetics across the globe includes Merck KGaA, Thermo Fisher Scientific, Inc., Abcam plc, Agilent Technologies, Active Motif, QIAGEN, Bio-Rad Laboratories, Inc., PerkinElmer Inc., New England Biolabs (NEB), and Illumina, Inc. among others. For instance, in February, 2018 QIAGEN launches epigenetic breast cancer test in Europe. In November 2015 Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership. Thus expanding its business in global epigenetics market.






 

TABLE OF CONTENTS

1. INTRODUCTION 22
1.1 SCOPE OF THE STUDY 22
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 22

2. GLOBAL EPIGENETICS MARKET - KEY TAKEAWAYS 24

3. GLOBAL EPIGENETICS MARKET - MARKET LANDSCAPE 27
3.1 OVERVIEW 27
3.2 MARKET SEGMENTATION 27
3.2.1 Global Epigenetics Market - By Product 28
3.2.2 Global Epigenetics Market - By Technology 28
3.2.3 Global Epigenetics Market - By Application 29
3.2.4 Global Epigenetics Market - By End User 29
3.2.5 Global Epigenetics Market - By Geography 29

4. GLOBAL EPIGENETICS MARKET - KEY MARKET DYNAMICS 30
4.1 KEY MARKET DRIVERS 30
4.1.1 Declining Prices of Sequencing 30
4.1.2 Increasing Prevalence of Cancer 30
4.1.3 Funds & Grants Provided By Government Bodies 30
4.2 KEY MARKET RESTRAINTS 31
4.2.1 High Cost of Advanced Technologies 31
4.2.2 Perception of the People For Genetic Alteration 31
4.3 KEY MARKET OPPORTUNITIES 32
4.3.1 Usage of NSG in Biomarker Discovery and Precision Medicine 32
4.3.2 Emerging Nations 32
4.4 KEY MARKET CHALLENGE 33
4.4.1 Lack of Skilled Professionals 33
4.5 FUTURE TRENDS 33
4.5.1 Promising Precise Treatments by Neurogenetics 33
4.6 IMPACT ANALYSIS 34

5. EPIGENETICS MARKET - GLOBAL ANALYSIS 35
5.1 GLOBAL EPIGENETICS MARKET REVENUE FORECASTS AND ANALYSIS 35
5.2 GLOBAL EPIGENETICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 36
5.3 MARKET POSITIONING 37
5.4 PERFORMANCE OF KEY PLAYERS 37
5.4.1 Thermo Fisher Scientific Inc. 37
5.4.2 Illumina, Inc. 37
5.5 EXPERT OPINIONS 38

6. GLOBAL EPIGENETICS MARKET ANALYSIS - BY PRODUCT 39
6.1 OVERVIEW 39
6.2 GLOBAL EPIGENETICS MARKET, BY PRODUCT, 2017 & 2025 (%) 39
6.3 REAGENTS MARKET 40
6.3.1 Overview 40
6.3.2 Global Reagents Market Revenue and Forecasts to 2025 (US$ Mn) 40
6.4 KITS MARKET 41
6.4.1 Overview 41
6.4.2 Global Kits Market Revenue and Forecasts to 2025 (US$ Mn) 41
6.5 ENZYMES MARKET 42
6.5.1 Overview 42
6.5.2 Global Enzymes Market Revenue and Forecasts to 2025 (US$ Mn) 42
6.6 INSTRUMENTS AND CONSUMABLES MARKET 43
6.6.1 Overview 43
6.6.2 Global Instruments and Consumables Market Revenue and Forecasts to 2025 (US$ Mn) 44
6.7 BIOINFORMATICS TOOLS MARKET 45
6.7.1 Overview 45
6.7.2 Global Bioinformatics Tools Market Revenue and Forecasts to 2025 (US$ Mn) 45

7. GLOBAL EPIGENETICS MARKET ANALYSIS - BY TECHNOLOGY 46
7.1 OVERVIEW 46
7.2 GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY, 2017 & 2025 (%) 46
7.3 HISTONE MODIFICATION MARKET 47
7.3.1 Overview 47
7.3.2 Global Histone Modification Market Revenue and Forecasts to 2025 (US$ Mn) 47
7.4 DNA METHYLATION MARKET 48
7.4.1 Overview 48
7.4.2 Global DNA Methylation Market Revenue and Forecasts to 2025 (US$ Mn) 48
7.5 OTHER TECHNOLOGIES MARKET 49
7.5.1 Overview 49
7.5.2 Global Other Technologies Market Revenue and Forecasts to 2025 (US$ Mn) 49

8. GLOBAL EPIGENETICS MARKET ANALYSIS - BY APPLICATION 50
8.1 OVERVIEW 50
8.2 GLOBAL EPIGENETICS MARKET, BY APPLICATION, 2017 & 2025 (%) 50
8.3 METABOLIC DISEASES MARKET 51
8.3.1 Overview 51
8.3.2 Global Metabolic Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 51
8.4 ONCOLOGY MARKET 52
8.4.1 Overview 52
8.4.2 Global Oncology Market Revenue and Forecasts to 2025 (US$ Mn) 52
8.5 CARDIOVASCULAR DISEASES MARKET 53
8.5.1 Overview 53
8.5.2 Global Cardiovascular Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 54
8.6 OTHER APPLICATIONS MARKET 55
8.6.1 Overview 55
8.6.2 Global Other Applications Market Revenue and Forecasts to 2025 (US$ Mn) 55

9. GLOBAL EPIGENETICS MARKET ANALYSIS - BY END USER 56
9.1 OVERVIEW 56
9.2 GLOBAL EPIGENETICS MARKET, BY END USER, 2017 & 2025 (%) 56
9.3 ACADEMIC & RESEARCH INSTITUTES MARKET 57
9.3.1 Overview 57
9.3.2 Global Academic & Research Institutes Market Revenue and Forecasts to 2025 (US$ Mn) 57
9.4 CONTRACT RESEARCH ORGANIZATIONS MARKET 58
9.4.1 Overview 58
9.4.2 Global Contract Research Organizations Market Revenue and Forecasts to 2025 (US$ Mn) 58
9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 59
9.5.1 Overview 59
9.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn) 59

10. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 60
10.1 OVERVIEW 60
10.2 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
10.3 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 61
10.4 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 62
10.5 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 62
10.6 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 62
10.7 NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 63
10.8 US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
10.8.1 US Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 65
10.8.2 US Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 65
10.8.3 US Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 66
10.8.4 US Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 66
10.8.5 US Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 66
10.9 CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
10.9.1 Canada Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 68
10.9.2 Canada Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 68
10.9.3 Canada Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 69
10.9.4 Canada Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 69
10.9.5 Canada Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 69
10.10 MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
10.10.1 Mexico Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 71
10.10.2 Mexico Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 71
10.10.3 Mexico Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 72
10.10.4 Mexico Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 72
10.10.5 Mexico Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 72

11. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 73
11.1 OVERVIEW 73
11.2 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
11.3 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
11.4 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 75
11.5 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 75
11.6 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 75
11.7 EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 76
11.8 UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
11.8.1 UK Epigenetics market Revenue and Forecasts to 2025 (US$ Mn) 78
11.8.2 UK Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 78
11.8.3 UK Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 79
11.8.4 UK Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 79
11.8.5 UK Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 79
11.9 GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 80
11.9.1 Germany Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 80
11.9.2 Germany Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 81
11.9.3 Germany Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 81
11.9.4 Germany Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 81
11.9.5 Germany Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 82
11.10 FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
11.10.1 France Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 84
11.10.2 France Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 84
11.10.3 France Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 85
11.10.4 France Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 85
11.10.5 France Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 85

12. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 86
12.1 OVERVIEW 86
12.2 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
12.3 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
12.4 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
12.5 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88
12.6 ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 88
12.7 ASIA PACIFIC GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 89
12.8 CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
12.8.1 China Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 90
12.8.2 China Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 90
12.8.3 China Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 91
12.8.4 China Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 91
12.8.5 China Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 91
12.9 JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
12.9.1 Japan Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 92
12.9.2 Japan Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 93
12.9.3 Japan Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 93
12.9.4 Japan Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 93
12.9.5 Japan Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 94
12.10 INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 95
12.10.1 India Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 96
12.10.2 India Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 96
12.10.3 India Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 97
12.10.4 India Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 97
12.10.5 India Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 97

13. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 98
13.1 OVERVIEW 98
13.2 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
13.3 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 99
13.4 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 100
13.5 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
13.6 MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 101
13.7 MIDDLE EAST AND AFRICA AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 101
13.8 UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 102
13.8.1 UAE Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 103
13.8.2 UAE Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 103
13.8.3 UAE Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 104
13.8.4 UAE Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 104
13.8.5 UAE Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 104
13.9 SAUDI ARABIA EPIGENTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
13.10 SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
13.10.1 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 106
13.10.2 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 106
13.10.3 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 106
13.10.4 Saudi Arabia Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 107
13.11 SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 107
13.12 SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 108
13.12.1 South Africa Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 108
13.12.2 South Africa Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 109
13.12.3 South Africa Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 109
13.12.4 South Africa Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 109

14. SOUTH AND CENTRAL AMERICA EPIGENTICS MARKET REVENUE AND FORECASTS TO 2025 110
14.1 OVERVIEW 110
14.2 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 111
14.3 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 111
14.4 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 112
14.5 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 112
14.6 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 113
14.7 SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 113
14.8 BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 114
14.8.1 Brazil Epigenetics Market Revenue and Forecasts to 2025 (US$ Mn) 114
14.8.2 Brazil Epigenetics Market Revenue And Forecasts to 2025, By Product (US$ Mn) 115
14.8.3 Brazil Epigenetics Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 115
14.8.4 Brazil Epigenetics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 115
14.8.5 Brazil Epigenetics Market Revenue And Forecasts to 2025, By End User (US$ Mn) 116

15. EPIGENETICS MARKET -INDUSTRY LANDSCAPE 117
15.1 OVERVIEW 117
15.2 GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 117
15.3 ORGANIC GROWTH STRATEGIES 118
15.3.1 Overview 118
15.3.2 Product Launches 118
15.3.3 Others 119
15.4 INORGANIC GROWTH STRATEGIES 119
15.4.1 Overview 119
15.4.2 Agreements 120
15.4.3 Acquisition 121

16. EPIGENETICS MARKET-KEY COMPANY PROFILES 122
16.1 MERCK KGAA 122
16.1.1 Key Facts 122
16.1.2 Business Description 122
16.1.3 Financial Overview 123
16.1.4 Product Portfolio 123
16.1.5 SWOT Analysis 124
16.1.6 Key Developments 125
16.2 THERMO FISHER SCIENTIFIC, INC. 126
16.2.1 Key Facts 126
16.2.2 Business Description 126
16.2.3 Financial Information 127
16.2.4 Product Portfolio 127
16.2.5 SWOT Analysis 128
16.2.6 Key Developments 128
16.3 ABCAM PLC 129
16.3.1 Key Facts 129
16.3.2 Business Description 129
16.3.3 Financial Overview 130
16.3.4 Product Portfolio 130
16.3.5 SWOT Analysis 131
16.3.6 Key Developments 132
16.4 AGILENT TECHNOLOGIES, INC. 133
16.4.1 Key Facts 133
16.4.2 Business Description 133
16.4.3 Financial Overview 134
16.4.4 Product Portfolio 134
16.4.5 SWOT Analysis 135
16.4.6 Key Developments 135
16.5 QIAGEN 136
16.5.1 Key Facts 136
16.5.2 Business Description 136
16.5.3 Financial Overview 137
16.5.4 Product Portfolio 137
16.5.5 SWOT Analysis 138
16.5.6 Key Developments 138
16.6 BIO-RAD LABORATORIES, INC. 139
16.6.1 Key Facts 139
16.6.2 Business Description 139
16.6.3 Financial Information 140
16.6.4 Product Portfolio 140
16.6.5 SWOT Analysis 141
16.6.6 Key Developments 141
16.7 ACTIVE MOTIF 142
16.7.1 Key Facts 142
16.7.2 Business Description 142
16.7.3 Financial Overview 142
16.7.4 Product Portfolio 143
16.7.5 SWOT Analysis 144
16.7.6 Key Developments 144
16.8 PERKIN ELMER, INC. 145
16.8.1 Key Facts 145
16.8.2 Business Description 145
16.8.3 Financial Overview 146
16.8.4 Product Portfolio 146
16.8.5 SWOT Analysis 147
16.8.6 Key Developments 147
16.9 NEW ENGLAND BIOLABS 148
16.9.1 Key Facts 148
16.9.2 Business Description 148
16.9.3 Financial Overview 148
16.9.4 Product Portfolio 148
16.9.5 SWOT Analysis 150
16.9.6 Key Developments 150
16.10 ILLUMINA, INC. 151
16.10.1 Key Facts 151
16.10.2 Business Description 151
16.10.3 Financial Overview 152
16.10.4 Product Portfolio 152
16.10.5 SWOT Analysis 153
16.10.6 Key Developments 153

17. APPENDIX 154
17.1 ABOUT THE INSIGHT PARTNERS 154
17.2 GLOSSARY OF TERMS 155
17.3 METHODOLOGY 157
17.3.1 Coverage 158
17.3.2 Secondary Research 158
17.3.3 Primary Research 159

LIST OF TABLES

TABLE 1. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 61
TABLE 2. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 62
TABLE 3. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 62
TABLE 4. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 62
TABLE 5. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 65
TABLE 6. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 66
TABLE 7. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 66
TABLE 8. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 66
TABLE 9. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 68
TABLE 10. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 69
TABLE 11. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
TABLE 12. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 69
TABLE 13. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 71
TABLE 14. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 72
TABLE 15. MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 72
TABLE 16. MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 72
TABLE 17. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
TABLE 18. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 75
TABLE 19. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 75
TABLE 20. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 75
TABLE 21. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 78
TABLE 22. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 79
TABLE 23. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
TABLE 24. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 79
TABLE 25. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 81
TABLE 26. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 81
TABLE 27. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81
TABLE 28. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 82
TABLE 29. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 84
TABLE 30. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 85
TABLE 31. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 85
TABLE 32. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 85
TABLE 33. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
TABLE 34. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
TABLE 35. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88
TABLE 36. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 88
TABLE 37. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 90
TABLE 38. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 91
TABLE 39. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 91
TABLE 40. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 91
TABLE 41. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 93
TABLE 42. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 93
TABLE 43. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 93
TABLE 44. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 94
TABLE 45. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
TABLE 46. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 97
TABLE 47. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
TABLE 48. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
TABLE 49. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 99
TABLE 50. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 100
TABLE 51. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
TABLE 52. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 101
TABLE 53. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 101
TABLE 54. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 103
TABLE 55. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 104
TABLE 56. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104
TABLE 57. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 104
TABLE 58. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 106
TABLE 59. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 106
TABLE 60. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 106
TABLE 61. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 107
TABLE 62. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 108
TABLE 63. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 109
TABLE 64. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 109
TABLE 65. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 109
TABLE 66. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 111
TABLE 67. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 112
TABLE 68. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 112
TABLE 69. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 113
TABLE 70. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 115
TABLE 71. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 115
TABLE 72. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 115
TABLE 73. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 116
TABLE 74. RECENT PRODUCT LAUNCHES IN THE EPIGENETICS MARKET 118
TABLE 75. RECENT OTHERS IN THE EPIGENETICS MARKET 119
TABLE 76. AGREEMENTS INORGANIC DEVELOPMENTS IN THE EPIGENETICS MARKET 120
TABLE 77. ACQUISITIONS IN THE EPIGENETICS MARKET 121
TABLE 78. GLOSSARY OF TERMS, EPIGENETICS MARKET 155

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC EPIGENETICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 24
FIGURE 2. GLOBAL EPIGENETICS MARKET BY PRODUCT, MARKET SHARE (%), 2017 25
FIGURE 3. GLOBAL EPIGENETICS MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017 25
FIGURE 4. GLOBAL EPIGENETICS MARKET BY APPLICATION, MARKET SHARE (%), 2017 26
FIGURE 5. GLOBAL EPIGENETICS MARKET BY END USER, MARKET SHARE (%), 2017 26
FIGURE 6. EPIGENETICS MARKET SEGMENTATION 27
FIGURE 7. EPIGENETICS SEGMENTATION, BY REGION 28
FIGURE 8. EPIGENETICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS 34
FIGURE 9. GLOBAL EPIGENETICS MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025 35
FIGURE 10. GLOBAL EPIGNETICS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 36
FIGURE 11. GLOBAL EPIGENETICS MARKET BY PRODUCT, 2017 & 2025 (%) 39
FIGURE 12. GLOBAL REAGENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 40
FIGURE 13. GLOBAL KITS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 41
FIGURE 14. GLOBAL ENZYMES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 42
FIGURE 15. GLOBAL INSTRUMENTS AND CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
FIGURE 16. GLOBAL BIOINFORMATICS TOOLS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 17. GLOBAL EPIGENETICS MARKET BY TECHNOLOGY, 2017 & 2025 (%) 46
FIGURE 18. GLOBAL HISTONE MODIFICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 19. GLOBAL DNA METHYLATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 20. GLOBAL OTHERS TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
FIGURE 21. GLOBAL EPIGENETICS MARKET BY APPLICATION, 2017 & 2025 (%) 50
FIGURE 22. GLOBAL METABOLIC DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 23. GLOBAL ONCOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 24. GLOBAL CARDIOVASCULAR DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 25. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 26. GLOBAL EPIGENETICS MARKET BY END USER, 2017 & 2025 (%) 56
FIGURE 27. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 28. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 29. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 30. NORTH AMERICA EPIGENETICS MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN) 60
FIGURE 31. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 32. NORTH AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 63
FIGURE 33. US EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
FIGURE 34. CANADA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 35. MEXICO EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
FIGURE 36. EUROPE EPIGENETICS MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN) 73
FIGURE 37. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
FIGURE 38. EUROPE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 76
FIGURE 39. UK EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
FIGURE 40. GERMANY EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 80
FIGURE 41. FRANCE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84
FIGURE 42. ASIA PACIFIC EPIGENETICS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 86
FIGURE 43. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
FIGURE 44. ASIA PACIFIC EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 89
FIGURE 45. CHINA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 90
FIGURE 46. JAPAN EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
FIGURE 47. INDIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 48. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 98
FIGURE 49. MIDDLE EAST AND AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
FIGURE 50. UAE EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
FIGURE 51. SAUDI ARABIA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
FIGURE 52. SOUTH AFRICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 108
FIGURE 53. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 110
FIGURE 54. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 111
FIGURE 55. SOUTH AND CENTRAL AMERICA EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 113
FIGURE 56. BRAZIL EPIGENETICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 114
FIGURE 57. GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 117
FIGURE 58. ORGANIC GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 118
FIGURE 59. INORGANIC GROWTH STRATEGIES IN THE EPIGENETICS MARKET, 2015-2018 119
The List of Companies

1. Merck KGaA
2. Thermo Fisher Scientific, Inc.
3. Abcam plc
4. Agilent Technologies
5. Active Motif
6. QIAGEN
7. Bio-Rad Laboratories, Inc.
8. PerkinElmer Inc.
9. New England Biolabs (NEB)
10. Illumina, Inc.




      • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the epigenetics market.







      • Highlights key business priorities in order to assist companies to realign their business strategies.







      • The key findings and recommendations highlight crucial progressive industry trends in the global epigenetics market, thereby allowing players across the value chain to develop effective long-term strategies.







      • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.







      • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.







      • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550